Human papillomavirus testing versus cytology in primary cervical cancer screening: End-of-study and extended follow-up results from the Canadian cervical cancer screening trial

A birth cohort analysis of the incidence of adenocarcinoma of the uterine cervix in the USA

(2015) Cairong Zhu et al.   EUROPEAN JOURNAL OF CANCER PREVENTION

Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test

(2015) Thomas C. Wright et al.   GYNECOLOGIC ONCOLOGY

The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds

(2014) Henry C Kitchener et al.   HEALTH TECHNOLOGY ASSESSMENT

Reassurance Against Future Risk of Precancer and Cancer Conferred by a Negative Human Papillomavirus Test

(2014) J. C. Gage et al.   JNCI-Journal of the National Cancer Institute

Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial

(2014) K. M. Elfstrom et al.   BMJ-British Medical Journal

Recommendations on screening for cervical cancer

(2013)   CANADIAN MEDICAL ASSOCIATION JOURNAL

cobas®4800 HPV Test, a real-time polymerase chain reaction assay for the detection of human papillomavirus in cervical specimens

(2013) Sandra D Isidean et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

(2013) Guglielmo Ronco et al.   LANCET

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer

(2012) Debbie Saslow et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: Background and Consensus Recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology

(2012) Teresa M. Darragh et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Clinical Human Papillomavirus Detection Forecasts Cervical Cancer Risk in Women Over 18 Years of Follow-Up

(2012) Philip E. Castle et al.   JOURNAL OF CLINICAL ONCOLOGY

Cervical Cancer Trends in the United States: A 35-Year Population-Based Analysis

(2012) Olusola Adegoke et al.   JOURNAL OF WOMENS HEALTH

Introduction of Human Papillomavirus DNA Screening in the World: 15 Years of Experience

(2012) Philip E. Castle et al.   VACCINE

Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer

(2012) Marc Arbyn et al.   VACCINE

Evaluation of HPV-16 and HPV-18 Genotyping for the Triage of Women With High-Risk HPV+ Cytology-Negative Results

(2011) Thomas C. Wright et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Persistence of Type-Specific Human Papillomavirus Infection and Increased Long-term Risk of Cervical Cancer

(2011) H.-C. Chen et al.   JNCI-Journal of the National Cancer Institute

Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice

(2011) Hormuzd A Katki et al.   LANCET ONCOLOGY

Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial

(2011) Dorien C Rijkaart et al.   LANCET ONCOLOGY

Long-term Absolute Risk of Cervical Intraepithelial Neoplasia Grade 3 or Worse Following Human Papillomavirus Infection: Role of Persistence

(2010) S. K. Kjaer et al.   JNCI-Journal of the National Cancer Institute

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

(2010) Guglielmo Ronco et al.   LANCET ONCOLOGY

A review of human carcinogens—Part B: biological agents

(2009) Véronique Bouvard et al.   LANCET ONCOLOGY

Epidemiology and Natural History of Human Papillomavirus Infections and Type-Specific Implications in Cervical Neoplasia

(2008) F. Xavier Bosch et al.   VACCINE